Janssen Biotech, Inc., formerly Centocor Biotech, Inc., is a biotechnology company.
Business Model:
Revenue: $0
Employees: 10,001-1
Address:
City: Horsham
State: Pennsylvania
Zip:
Country: United States
Janssen Biotech, Inc. has delivered on the promise of new treatments and new ways to improve the health of individuals with serious disease. Built upon a rich legacy of innovative "firsts," Janssen Biotech, Inc. pursues innovative solutions in the therapeutic areas of immunology, oncology, and nephrology. With the same unwavering passion for new challenges, They dedicate ourselves to delivering solutions for these disease states where unmet needs continue to exist.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
5/2020 | Halozyme Therapeutics | Post-IPO Equity | 0 |
7/2013 | Amphivena Therapeutics | Series A | 0 |
5/2020 | Halozyme Therapeutics | Post-IPO Equity | 0 |
7/2013 | Amphivena Therapeutics | Series A | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
---|
Announced Date | Name | Price |
---|---|---|
5/2018 | BeneVir Biopharm | |
1/2008 | Centocor Ortho Biotech |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|